Multimodal brain data foundation
VergeDB aggregates multimodal patient brain data collected over more than a decade, including transcriptomic, genetic, proteomic, single-cell, biomarker, and clinical annotations.
Verge Labs
Freemium
AI platform combining brain data and foundation models for neurological disease research
What is Verge Labs?
Verge Labs is an AI platform for human biology with a specific focus on neuroscience and neurological disease. It combines a proprietary multimodal patient brain dataset with foundation models built to reason about patient biology, then applies those models to drug discovery and clinical development workflows.
The core product story is anchored in human tissue rather than proxy data alone. VergeDB includes brain tissue, genetics, clinical annotations, and other molecular layers drawn from thousands of patients, while vBx-1.0 and CONVERGE turn that data into patient-level predictions for target selection, biomarker discovery, patient stratification, and trial design.
What can Verge Labs do?
Patient-level foundation models
vBx-1.0 links brain biology, longitudinal biofluids, and clinical trajectory into a unified patient representation, then infers brain state from accessible inputs such as blood, imaging, and clinical attributes.
Target discovery from human tissue
The platform can surface causal disease signatures and identify genes that, when modulated, may shift a patient’s brain state toward health.
Patient stratification and biomarker work
CONVERGE stratifies cohorts by molecular endotype rather than diagnosis to find the patients most likely to benefit and the biomarkers likely to move earliest.
Program enablement workflows
Program teams can use the platform to stress-test preclinical and translational decisions against real human patient biology, including indication expansion questions.
Customizable to a program
The model can be fine-tuned with program- and trial-specific data to sharpen accuracy for individual molecules and study contexts.
Use Cases
“Novel target discovery”
Teams can use the platform to identify genes and pathways that are most likely to change disease biology in human brain tissue, rather than relying only on animal proxies.
“Program enablement”
Once a target is chosen, program teams can assess whether the biology translates across patient subgroups, preclinical models, and indications before moving deeper into development.
“Clinical trial optimization”
Clinical teams can stratify trial populations by molecular endotype and identify biomarkers that should move early in response to treatment.
“Patient-level molecular inference”
Scientists can infer brain molecular state from blood, imaging, and clinical attributes to obtain a virtual biopsy when direct tissue sampling is not possible.
“Human disease modeling”
Research teams can use the dataset to study disease signatures across multimodal human samples and annotate how biology varies over time and across patient groups.
Frequently Asked Questions
What does Verge Labs focus on?
Verge Labs presents the platform as starting with the brain and using multimodal human tissue, blood, genetics, imaging, and clinical data to reason about neurological disease at the patient level.
Who is the platform for?
The platform is aimed at drug developers working in neuroscience and precision neurology, especially teams deciding which targets to pursue, which patients to study, and how to structure trials.
What is a virtual biopsy in this context?
The source describes vBx-1.0 as a foundation model that can infer molecular brain state from more accessible modalities such as blood, imaging, and clinical attributes, producing a virtual biopsy of the brain.
What kinds of work does the platform support?
The platform is positioned for target discovery, target characterization, biomarker identification, patient stratification, program enablement, and clinical trial optimization.
Is pricing published on the site?
The pricing page at the provided URL returns a 404, so the source does not provide pricing details.
Quick Facts
- Category
- AI platform for human biology
- Primary focus
- Neuroscience and neurological disease
- Core platform names
- VergeDB, vBx-1.0, CONVERGE
- Data scale
- 12,000+ brains and 6,000+ patients/controls
- Source domain
- vergegenomics.com
- Pricing
- Not publicly listed; pricing URL returns 404
Verge Labs Traffic Analysis
Traffic data is for reference only.
- Domain Rating
- 48
Verge Labs Alternatives
Dr.Oracle
droracle.ai
Medical AI for cited, guideline-based clinical answers and research
H1
h1.co
H1 is an AI-powered healthcare data platform for life sciences, pharma, and research teams.
Segmed
segmed.ai
Real-world medical imaging data platform with de-identified datasets and self-serve search
1910
1910genetics.com
1910 is an AI-native biotech using ITO™ for multimodal drug discovery.
Rayyan
rayyan.ai
AI-powered platform for systematic and literature reviews
Anara
unriddle.ai
Anara is an AI research workspace for cited answers, document analysis, and web and library search.